Search

Author/Creator Praus, Michaela

1. 18. Secondary endpoints (PATH extension study): Long-term outcomes of subcutaneous immunoglobulin IgPro20 in CIDP maintenance treatment. Issue 3 (March 2020)

Authors:
van Schaik, Ivo N.; Mielke, Orell; Bril, Vera; Hartung, Hans-Peter; Lewis, Richard A.; Sobue, Gen; Lawo, John-Philip; Praus, Michaela; Durn, Billie L.; Cornblath, David R.; J. Merkies, Ingemar S.
Journal:
Clinical neurophysiology
Issue:
Volume 131:Issue 3(2020:Mar.)
Page Start:
e8
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long-term safety and efficacy of subcutaneous immunoglobulin IgPro20 in CIDP: PATH extension study. Issue 5 (September 2019)

Authors:
van Schaik, Ivo N.; Mielke, Orell; Bril, Vera; van Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A.; Sobue, Gen; Lawo, John-Philip; Praus, Michaela; Durn, Billie L.; Cornblath, David R.; Merkies, Ingemar S. J.
Journal:
Neurology
Issue:
Volume 6:Issue 5(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency. Issue 6 (8th December 2019)

Authors:
Rojavin, Mikhail A.; Chapdelaine, Hugo; Tortorici, Michael A.; Praus, Michaela; Baheti, Gautam; Zhang, Ying; Hofmann, Jutta; Labrosse, Roxane; Dicaire, Renée; Haddad, Elie
Journal:
Clinical pharmacology in drug development
Issue:
Volume 9:Issue 6(2020)
Page Start:
664
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Pharmacometric analysis linking immunoglobulin exposure to clinical efficacy outcomes in chronic inflammatory demyelinating polyneuropathy. (1st August 2021)

Authors:
Tortorici, Michael A.; Yuraszeck, Theresa; Cornblath, David; Bril, Vera; Hartung, Hans‐Peter; Sobue, Gen; Lewis, Richard A.; Merkies, Ingemar S. J.; Lawo, John‐Philip; Praus, Michaela; Durn, Billie L.; Mielke, Orell; Ma, Xuewen; Jauslin, Petra; Pfister, Marc; van Schaik, Ivo N.
Journal:
CPT: pharmacometrics & systems pharmacology
Issue:
Volume 10:Number 8(2021)
Page Start:
839
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2018)

Authors:
van Schaik, Ivo N; Bril, Vera; van Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A; Sobue, Gen; Lawo, John-Philip; Praus, Michaela; Mielke, Orell; Durn, Billie L; Cornblath, David R; Merkies, Ingemar S J
Journal:
Lancet neurology
Issue:
Volume 17:Issue 1(2018)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2018)

Authors:
van Schaik, Ivo N; Bril, Vera; van Geloven, Nan; Hartung, Hans-Peter; Lewis, Richard A; Sobue, Gen; Lawo, John-Philip; Praus, Michaela; Mielke, Orell; Durn, Billie L; Cornblath, David R; Merkies, Ingemar S J; Sabet, A.; George, K.; Roberts, L.; Carne, R.; Blum, S.; Henderson, R.; Van Damme, P.; D...
Journal:
Lancet neurology
Issue:
Volume 17:Issue 1(2018)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗